LabMedica

Download Mobile App
Recent News Expo Clinical Chem. Molecular Diagnostics Hematology Immunology Microbiology Pathology Technology Industry Focus

Folic Acid Deficiency Linked to Parkinson's

By Biotechdaily staff writers
Posted on 20 May 2002
Folic acid deficiency may increase the brain's susceptibility to Parkinson's disease, according to a mouse study conducted by scientists at the National Institute on Aging (NIA, Bethesda, MD, USA). The findings were reported in the January 2002 issue of the Journal of Neurochemistry.

The investigators fed one group of mice a diet that included folate, while a second group was fed a diet lacking this vitamin. The mice were then given moderate amounts of MPTP, a chemical that can cause symptoms similar to Parkinson's disease. In the mice fed folate, MPTP caused only mild symptoms of disease, but mice fed the folate-deficient diet developed severe symptoms of Parkinson's disease. The scientists found that mice with low amounts of dietary folic acid had elevated levels of homocysteine in the blood and brain. They suspect that increased homocysteine levels in the brain damaged the DNA of nerve cells in the substantia nigra, which produces dopamine.

Loss of dopamine causes nerve cells to dysfunction, resulting in the inability of patients to direct or control their movements in a normal way. In the folate-fed mice, dopamine-producing nerve cells were able to repair their damaged DNA and counteract the adverse effects of homocysteine. In folate-deficient mice, however, similar nerve cells were not able to repair their extensive DNA damage, so they died. The scientists noted that people with Parkinson's disease often have low levels of folic acid in their blood, but it is not known if this is a result of the disease process or if they are simply malnourished because of their illness. Based on this study, it would appear that consuming adequate amounts of folic acid could help protect the aging brain against Parkinson's and other neurodegenerative diseases.

"This is the first direct evidence that folic acid may have a key role in protecting adult nerve cells against age-related disease,” said Mark Mattson, Ph.D., chief of the NIA's
Laboratory of Neurosciences.



Related Links:
National Institute on Aging (NIA)
Gold Member
Quantitative POC Immunoassay Analyzer
EASY READER+
POC Helicobacter Pylori Test Kit
Hepy Urease Test
Alcohol Testing Device
Dräger Alcotest 7000
Urine Chemistry Control
Dropper Urine Chemistry Control

Channels

Molecular Diagnostics

view channel
Image: The diagnostic device can tell how deadly brain tumors respond to treatment from a simple blood test (Photo courtesy of UQ)

Diagnostic Device Predicts Treatment Response for Brain Tumors Via Blood Test

Glioblastoma is one of the deadliest forms of brain cancer, largely because doctors have no reliable way to determine whether treatments are working in real time. Assessing therapeutic response currently... Read more

Immunology

view channel
Image: Circulating tumor cells isolated from blood samples could help guide immunotherapy decisions (Photo courtesy of Shutterstock)

Blood Test Identifies Lung Cancer Patients Who Can Benefit from Immunotherapy Drug

Small cell lung cancer (SCLC) is an aggressive disease with limited treatment options, and even newly approved immunotherapies do not benefit all patients. While immunotherapy can extend survival for some,... Read more

Microbiology

view channel
Image: New evidence suggests that imbalances in the gut microbiome may contribute to the onset and progression of MCI and Alzheimer’s disease (Photo courtesy of Adobe Stock)

Comprehensive Review Identifies Gut Microbiome Signatures Associated With Alzheimer’s Disease

Alzheimer’s disease affects approximately 6.7 million people in the United States and nearly 50 million worldwide, yet early cognitive decline remains difficult to characterize. Increasing evidence suggests... Read more

Technology

view channel
Image: Vitestro has shared a detailed visual explanation of its Autonomous Robotic Phlebotomy Device (photo courtesy of Vitestro)

Robotic Technology Unveiled for Automated Diagnostic Blood Draws

Routine diagnostic blood collection is a high‑volume task that can strain staffing and introduce human‑dependent variability, with downstream implications for sample quality and patient experience.... Read more

Industry

view channel
Image: Roche’s cobas® Mass Spec solution enables fully automated mass spectrometry in routine clinical laboratories (Photo courtesy of Roche)

New Collaboration Brings Automated Mass Spectrometry to Routine Laboratory Testing

Mass spectrometry is a powerful analytical technique that identifies and quantifies molecules based on their mass and electrical charge. Its high selectivity, sensitivity, and accuracy make it indispensable... Read more